Clinical Trials Browser

Neoplasms, Second Primary × Head & Neck × Clear all

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT03377829 2021-03-19

A Multicenter Trial of PLA vs. Surgery for Treating PTMC

Phase NA Unknown

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms, Neoplasms, Second Primary

NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Phase 3 Completed

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

NCT00400426 2013-06-19

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Phase 2 Completed

Head and Neck Neoplasms, Recurrence, Neoplasms, Second Primary